Trending Case Studies

Harnessing Data Curation To Unlock a $330 Million Opportunity

Pharma Company Achieves 4x Faster Target Identification for Inflammatory Disease

Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation

Pharma-AI Collaboration Drives ~$3M Cost Reduction by Using Highly Curated Public Data

Leading Oncology Company Uses Elucidata’s Drug OmixAtlas to Drive Drug Discovery

Case study: Accelerated Target ID using ML-Ready data on Polly
Harnessing Data Curation To Unlock a $330 Million Opportunity
Case study: Accelerated Target ID using ML-Ready data on Polly
Biomarker Data Curation and Management with Polly
Case study: Accelerated Target ID using ML-Ready data on Polly
100% Automation and Cost Saving of ~$1.34M in Single-cell Data Compute and Processing
Case study: Accelerated Target ID using ML-Ready data on Polly
Pharma Company Achieves 4x Faster Target Identification for Inflammatory Disease
Case study: Accelerated Target ID using ML-Ready data on Polly
Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation
Case study: Accelerated Target ID using ML-Ready data on Polly
Pharma-AI Collaboration Drives ~$3M Cost Reduction by Using Highly Curated Public Data

Other Resources

WebinarsWhitepapersBlogsDocumentationDataset RoundupSolution Briefs
Login
Polly
Features
Technology
Data on Polly
Solutions
Pipeline Solutions
Curation on Demand
Applications
ML Solutions
BY ROLE
Biologists
Bioinformaticians
Data Custodians
Leadership
COMPANY
About Us
Team
Mission
Careers

© All Rights Reserved, 2023

Privacy PolicyTerms of ServiceWebsite Terms of Service